Payment overview · 2025
General Payments
$35.84
2 reported records · 2 companies
Healthcare provider profile · identity verified
Vivian Torres, ARNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · PLANTATION, FL · NPI 1386048338
Verified facts
What the public records show
CMS Open Payments records show Vivian Torres, ARNP received $35.84 in general payments during 2025 across 2 reported records.
Novo Nordisk Inc accounted for 56.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $20.07 | 56.0% | 1 | 2025 |
| CashFlow Solutions, LLC | Unresolved — no canonical attribution shown | $15.77 | 44.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.84 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $20.07 | 1 | 2025 |
Source payment records
|
|||||
| LYMPHA PRESS OPTIMAL PLUS(US) BT Normalized: lympha press optimal plus us bt |
Device | CashFlow Solutions, LLC | $15.77 | 1 | 2025 |
Source payment records
|
|||||
| PCD-51 731A (US) - White Normalized: pcd 51 731a us white |
Device | CashFlow Solutions, LLC | $15.77 | 1 | 2025 |
Source payment records
|
|||||
| PCD-52 737A (US) White Normalized: pcd 52 737a us white |
Device | CashFlow Solutions, LLC | $15.77 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 634 | 155 |
| Atorvastatin Calcium | Atorvastatin Calcium | 534 | 220 |
| Levothyroxine Sodium | Levothyroxine Sodium | 493 | 121 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 415 | 155 |
| Losartan Potassium | Losartan Potassium | 361 | 122 |
| Metformin Hcl | Metformin Hcl | 342 | 108 |
| Amlodipine Besylate | Amlodipine Besylate | 336 | 112 |
| Gabapentin | Gabapentin | 322 | 103 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 270 | 145 |
| Escitalopram Oxalate | Escitalopram Oxalate | 250 | 64 |
| Lisinopril | Lisinopril | 247 | 79 |
| Alendronate Sodium | Alendronate Sodium | 235 | 67 |
| Metoprolol Succinate | Metoprolol Succinate | 235 | 65 |
| Omeprazole | Omeprazole | 226 | 70 |
| Folic Acid | Folic Acid | 217 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 195 | 62 |
| Glipizide | Glipizide | 185 | 50 |
| Methocarbamol | Methocarbamol | 180 | 113 |
| Donepezil Hcl | Donepezil Hcl | 172 | 51 |
| Alprazolam | Alprazolam | 153 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 153 | 48 |
| Trazodone Hcl | Trazodone Hcl | 153 | 49 |
| Montelukast Sodium | Montelukast Sodium | 147 | 54 |
| Memantine Hcl | Memantine Hcl | 143 | 55 |
| Carvedilol | Carvedilol | 132 | 43 |
| Chlorthalidone | Chlorthalidone | 129 | 34 |
| Mirtazapine | Mirtazapine | 122 | 33 |
| Sildenafil Citrate | Sildenafil Citrate | 116 | 25 |
| Glimepiride | Glimepiride | 111 | 37 |
| Famotidine | Famotidine | 110 | 39 |
| Metoprolol Tartrate | Metoprolol Tartrate | 106 | 34 |
| Benzonatate | Benzonatate | 102 | 87 |
| Ciclopirox | Ciclopirox | 97 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 97 | 38 |
| Latanoprost | Latanoprost | 96 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 94 | 50 |
| Temazepam | Temazepam | 91 | 14 |
| Allopurinol | Allopurinol | 90 | 20 |
| Clonazepam | Clonazepam | 87 | 18 |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 87 | 14 |
| Meloxicam | Meloxicam | 86 | 67 |
| Simvastatin | Simvastatin | 84 | 35 |
| Clopidogrel | Clopidogrel Bisulfate | 78 | 28 |
| Eliquis | Apixaban | 76 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 75 | 29 |
| Azithromycin | Azithromycin | 74 | 70 |
| Glipizide Er | Glipizide | 71 | 23 |
| Trueplus Pen Needle | Pen Needle, Diabetic | 69 | 16 |
| Nifedipine Er | Nifedipine | 68 | 27 |
| Buspirone Hcl | Buspirone Hcl | 67 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 67 | 19 |
| Sertraline Hcl | Sertraline Hcl | 67 | 26 |
| Enalapril Maleate | Enalapril Maleate | 61 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 61 | 20 |
| Fenofibrate | Fenofibrate | 59 | 21 |
| Ketoconazole | Ketoconazole | 59 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | 17 |
| Furosemide | Furosemide | 53 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 53 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 53 | 17 |
| Xarelto | Rivaroxaban | 53 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 44 |
| Ammonium Lactate | Ammonium Lactate | 47 | 21 |
| Meclizine Hcl | Meclizine Hcl | 47 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 45 | 15 |
| Amoxicillin | Amoxicillin | 44 | 39 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 43 | 14 |
| Atenolol | Atenolol | 41 | 15 |
| Baclofen | Baclofen | 40 | 21 |
| Tadalafil | Tadalafil | 38 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 37 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 36 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 36 | 14 |
| Methenamine Hippurate | Methenamine Hippurate | 35 | 11 |
| Spironolactone | Spironolactone | 35 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 26 |
| Finasteride | Finasteride | 34 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 33 | 13 |
| Methylprednisolone | Methylprednisolone | 33 | 27 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 32 | 15 |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | 22 |
| Novolog Flexpen | Insulin Aspart | 31 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 31 | suppressed |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 30 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | suppressed |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 24 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 23 | suppressed |
| Lactulose | Lactulose | 23 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 21 |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 22 | 13 |
| Lovastatin | Lovastatin | 22 | suppressed |
| Naproxen | Naproxen | 22 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 21 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 21 | suppressed |
| Torsemide | Torsemide | 21 | suppressed |
| Ibuprofen | Ibuprofen | 20 | 13 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 20 | 17 |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Sucralfate | Sucralfate | 18 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 18 | 11 |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Acyclovir | Acyclovir | 17 | 12 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | 16 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 17 | suppressed |
| Irbesartan | Irbesartan | 17 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 17 | 15 |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Prednisone | Prednisone | 17 | suppressed |
| Alogliptin | Alogliptin Benzoate | 16 | suppressed |
| Amantadine | Amantadine Hcl | 16 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 16 | suppressed |
| Lorazepam | Lorazepam | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Lumigan | Bimatoprost | 15 | suppressed |
| Methotrexate | Methotrexate Sodium | 15 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | 13 |
| Trueplus Insulin Syringe | Syringe And Needle,insulin,1ml | 14 | suppressed |
| Trueplus Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 14 | suppressed |
| Metronidazole | Metronidazole | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.84 · 2 records | Novo Nordisk Inc | LYMPHA PRESS OPTIMAL PLUS(US) BT, PCD-51 731A (US) - White, PCD-52 737A (US) White, Wegovy | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error